Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126571435 | 12657143 | 5 | F | 20160824 | 20160816 | 20160901 | EXP | PHJP2016JP023089 | SANDOZ | HIROSE T, IWAMI D, HATANAKA K, OKADA H, SASAKI H, HIGUCHI H, TAKADA Y ET AL.. A CASE OF KIDNEY TRANSPLANT PATIENT WITH GRANULOMATOUS INTERSTITIAL NEPHRITIS. THE 20TH JAPANESE CLINICOPATHOLOGICAL CONFERENCE ON RENAL ALLOGRAFT PATHOLOGY. 43 | 52.00 | YR | M | Y | 0.00000 | 20160901 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126571435 | 12657143 | 1 | PS | NEORAL | CYCLOSPORINE | 1 | Oral | UNK | Y | 0 | CAPSULE | ||||||||
| 126571435 | 12657143 | 2 | SS | NEORAL | CYCLOSPORINE | 1 | Y | 0 | CAPSULE | ||||||||||
| 126571435 | 12657143 | 3 | SS | SIMULECT | BASILIXIMAB | 1 | Unknown | UNK | Y | 0 | SOLUTION FOR INJECTION | ||||||||
| 126571435 | 12657143 | 4 | SS | SIMULECT | BASILIXIMAB | 1 | Y | 0 | SOLUTION FOR INJECTION | ||||||||||
| 126571435 | 12657143 | 5 | SS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | UNK | Y | 0 | CAPSULE | ||||||||
| 126571435 | 12657143 | 6 | SS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Y | 0 | CAPSULE | ||||||||||
| 126571435 | 12657143 | 7 | SS | MEDROL | METHYLPREDNISOLONE | 1 | Oral | UNK | Y | 0 | TABLET | ||||||||
| 126571435 | 12657143 | 8 | SS | MEDROL | METHYLPREDNISOLONE | 1 | Y | 0 | TABLET | ||||||||||
| 126571435 | 12657143 | 9 | C | EVEROLIMUS | EVEROLIMUS | 1 | Oral | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126571435 | 12657143 | 1 | Renal transplant |
| 126571435 | 12657143 | 2 | Immunosuppressant drug therapy |
| 126571435 | 12657143 | 3 | Renal transplant |
| 126571435 | 12657143 | 4 | Immunosuppressant drug therapy |
| 126571435 | 12657143 | 5 | Renal transplant |
| 126571435 | 12657143 | 6 | Immunosuppressant drug therapy |
| 126571435 | 12657143 | 7 | Renal transplant |
| 126571435 | 12657143 | 8 | Immunosuppressant drug therapy |
| 126571435 | 12657143 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126571435 | 12657143 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126571435 | 12657143 | IgA nephropathy | |
| 126571435 | 12657143 | Immunosuppressant drug level increased | |
| 126571435 | 12657143 | Infection | |
| 126571435 | 12657143 | Polyomavirus-associated nephropathy | |
| 126571435 | 12657143 | Renal impairment | |
| 126571435 | 12657143 | Tubulointerstitial nephritis | |
| 126571435 | 12657143 | Wound infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |